BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12235279)

  • 1. Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
    Muratani T; Minami T; Enomoto U; Sakai M; Okuda-Ashitaka E; Kiyokane K; Mori H; Ito S
    J Pharmacol Exp Ther; 2002 Oct; 303(1):424-30. PubMed ID: 12235279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y; Simpson-Durand CD; Standifer KM
    Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury.
    Okuda-Ashitaka E; Minami T; Matsumura S; Takeshima H; Reinscheid RK; Civelli O; Ito S
    Eur J Neurosci; 2006 Feb; 23(4):995-1004. PubMed ID: 16519664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ.
    Nakano H; Minami T; Abe K; Arai T; Tokumura M; Ibii N; Okuda-Ashitaka E; Mori H; Ito S
    J Pharmacol Exp Ther; 2000 Jan; 292(1):331-6. PubMed ID: 10604967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation.
    Tamai H; Sawamura S; Takeda K; Orii R; Hanaoka K
    Eur J Pharmacol; 2005 Mar; 510(3):223-8. PubMed ID: 15763246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor.
    Okuda-Ashitaka E; Ito S
    Peptides; 2000 Jul; 21(7):1101-9. PubMed ID: 10998544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.
    Lee H
    Yonsei Med J; 2013 May; 54(3):763-71. PubMed ID: 23549827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801.
    Yamada H; Nakamoto H; Suzuki Y; Ito T; Aisaka K
    Br J Pharmacol; 2002 Jan; 135(2):323-32. PubMed ID: 11815367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr6] gamma2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice.
    Chang M; Li W; Peng YL; Gao YH; Yao J; Han RW; Wang R
    Brain Res; 2009 May; 1271():36-48. PubMed ID: 19332041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production.
    Mabuchi T; Matsumura S; Okuda-Ashitaka E; Kitano T; Kojima H; Nagano T; Minami T; Ito S
    Eur J Neurosci; 2003 Apr; 17(7):1384-92. PubMed ID: 12713641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
    Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
    J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
    Rizzi A; Nazzaro C; Marzola GG; Zucchini S; Trapella C; Guerrini R; Zeilhofer HU; Regoli D; Calo' G
    Pain; 2006 Sep; 124(1-2):100-8. PubMed ID: 16697109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor.
    Depner UB; Reinscheid RK; Takeshima H; Brune K; Zeilhofer HU
    Eur J Neurosci; 2003 Jun; 17(11):2381-7. PubMed ID: 12814369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
    J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.
    Wang JL; Zhu CB; Cao XD; Wu GC
    Regul Pept; 1999 Feb; 79(2-3):159-63. PubMed ID: 10100930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of silent and constitutively active nociceptin/orphanin FQ receptors by potent receptor antagonists and Na+ ions in rat sympathetic neurons.
    Mahmoud S; Margas W; Trapella C; Caló G; Ruiz-Velasco V
    Mol Pharmacol; 2010 May; 77(5):804-17. PubMed ID: 20159949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection.
    Suaudeau C; Florin S; Meunier JC; Costentin J
    Fundam Clin Pharmacol; 1998; 12(4):420-5. PubMed ID: 9711464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.